Forte80™ - How Does Probiotic Support Work for GLP-1 Weight Loss Journey
Forte80™ is a Swiss-developed, European-manufactured probiotic, specifically designed to support individuals using GLP-1 medications such as Ozempic, Wegovy, Zepbound, Mounjaro, and Rybelsus.
The flagship innovation from Azento Health, Forte80™ combines high potency, patented strains, and a research-driven formulation to provide targeted support for gut health and nutrient absorption, while reducing common GLP-1 gastrointestinal side effects, helping patients stay on track with their therapy.
Explore how the Forte80™ probiotic for weight loss with GLP-1s works, from its powerful composition to high quality manufacturing and protective packaging.
What Is Forte80™ and How Does It Work?
Forte80™ is a high-strength probiotic supplement, developed specifically to support individuals using GLP-1 (glucagon-like peptide-1) receptor agonists, medications such as Wegovy, Mounjaro, or Ozempic, as part of their health and weight management journey.
GLP-1 therapies are clinically proven to aid weight loss by suppressing appetite, slowing digestion, and delaying gastric emptying. While effective in helping patients reduce calorie intake and achieve significant weight loss, these same mechanisms often disrupt the digestive system, particularly in the early stages of treatment.
Common gastrointestinal (GI) side effects include nausea, vomiting, bloating, constipation, and diarrhoea. In fact, real-world evidence suggests that up to 70% of GLP-1 users experience discomfort of varying intensity, and for many, these unpleasant symptoms reduce quality-of-life and can be severe enough to cause treatment discontinuation before their health goals are met.
Reduced food intake and changes in gut motility can also compromise the gut microbiome, disrupting microbial diversity, and weakening the gut barrier. Additionally, this can reduce the production of short-chain fatty acids (SCFAs), crucial compounds that help regulate inflammation, support gut lining integrity, and influence appetite and energy balance.
Forte80™ is formulated to address these challenges directly:
- Restores microbiota balance and healthy motility. 83% of users report GLP-1 side effect relief.
- Helps maintain microbiome diversity and SCFA production during restricted food intake.
- Enhances satiety signalling, reduces cravings, and supports ongoing success with GLP-1 therapy.
- Facilitates absorption of crucial nutrients, especially minerals like calcium, magnesium, zinc.
- Helps supress pathogenic bacteria that can disrupt digestive processes.
Forte80™ Formulation
Each daily dose of Forte80™ delivers 80 billion CFU (colony-forming units) of four proprietary, scientifically validated probiotic strains carefully selected for their targeted benefits.
Bifidobacterium lactis AZHx1
Delivered in the highest amount of 45 billion CFU per daily dose, this strain supports micronutrient absorption, strengthens the gut barrier to help prevent unwanted substances from entering the bloodstream, and reduces inflammation in the digestive tract.
Lactobacillus casei AZHx3
Included at 15 billion CFU per dose, the strain contributes to stress resilience, supports healthy gut movement, and enhances immune function, all of which can be compromised during calorie restriction and digestive imbalance.
Lactobacillus rhamnosus GG
Also present at 15 billion CFU per daily dose, this is one of the most researched probiotic strains worldwide. It helps protect the gut lining and reduce the risk of diarrhoea, which is a common side effect of GLP-1 therapies.
Lactobacillus reuteri AZHx2
Supplied at 5 billion CFU per dose, this strain promotes immune balance and digestive comfort. It is derived from the clinically validated DSM 17938 lineage, well recognised for its safety and use in gastrointestinal support.
Manufacturing and Quality Assurance
Each probiotic strain in Forte80™ is thoroughly verified in two ways:
- Genotypically, using advanced DNA testing like 16S rRNA sequencing to confirm the exact identity of the strain.
- Phenotypically, through functional testing that checks how the strain behaves, including its resilience and ability to produce key compounds like short-chain fatty acids.
This two-step validation ensures that every strain does exactly what it is meant to do in the body.

Each probiotic strain in Forte80™ is protected by patent, which ensures a stable and precisely formulated product with consistent efficacy, unlike many generic probiotics, which can vary in quality and effectiveness from batch to batch. The supplement is manufactured in facilities within the EU that are certified under Good Manufacturing Practice (GMP), a quality assurance system that governs every aspect of production, from raw materials and equipment to hygiene standards and staff training. This helps maintain safe, consistent production at the highest quality standards.
The practices include comprehensive testing for colony-forming units (CFUs), potential contaminants such as Salmonella, E. coli, and heavy metals, as well as common allergens. Forte80™ is free from dairy, gluten, soy, and genetically modified organisms, and is fully compliant with EU food supplement regulations (Directive 2002/46/EC).
Technology-Driven Viability at 80 Billion CFU
Forte80™ stands out for its advanced stability profile - an essential feature that enables live, active probiotics to reach their target sites in the gut intact. This sets it apart from many conventional probiotics, which can lose over 50% of their viable cultures before they are even consumed.
High stability is achieved through a combination of carefully engineered technologies:

- CRYO-protection technology safeguards the probiotic strains during manufacturing, storage, and transit through the acidic environment of the stomach. This process helps preserve the integrity and viability of each strain until it reaches the intestines.
- Intrinsic acid resistance, enhanced by naturally upregulated mechanisms such as F0F1-ATPase proton pumps and the arginine deiminase pathway, further supports survival in harsh gastric conditions. These biological processes help the bacteria maintain pH balance and energy production in low pH environments.
- Plant-based HPMC (hydroxypropyl methylcellulose) capsules offer reliable release of probiotics throughout varying pH levels of the gastrointestinal tract.
- Aluminium blister packaging protects each capsule from moisture and oxygen exposure - two major factors that degrade probiotic viability. This high-barrier packaging preserves full potency for up to 24 months at room temperature.
Together, these technologies, paired with strict quality control, guarantee a minimum of 80 billion colony-forming units (CFU) per daily dose right up to the product’s expiry date.
Forte80™ Benefits for GLP-1 Users and Beyond
Forte80™ has been specifically formulated to support individuals undergoing GLP-1 therapy by replenishing beneficial gut flora and helping to ease common gastrointestinal side effects such as nausea, diarrhoea, constipation, and bloating.
According to user-reported data, 83% of GLP-1 patients experienced a noticeable improvement in gastrointestinal symptoms within 7 to 14 days of starting Forte80™. In addition, the postbiotic compounds produced by the probiotic strains in the formulation may help enhance the body’s own production of GLP-1 and leptin, further supporting appetite regulation and metabolic function. Improved gut comfort and reduced intestinal inflammation may also encourage better adherence to prescribed medications and greater consistency with dietary habits.
Importantly, the benefits of Forte80™ are not limited to those using GLP-1 medications. The supplement may offer a range of broader health advantages for general digestive and metabolic wellbeing, including:
- Support for digestive processes, such as intestinal motility, nutrient absorption, and reduction in bloating.
- Strengthening of the intestinal barrier and suppression of pro-inflammatory microbes, including Klebsiella spp. and Clostridioides difficile.
- Improved immune modulation through the regulation of inflammatory pathways associated with metabolic disorders.
- Promotion of short-chain fatty acid (SCFA) production, aiding in energy balance and appetite signalling.
- Positive influence on mental wellbeing through interactions along the gut-brain axis.
How to Use Forte80™
For best results, take two capsules daily before breakfast and continue consistently for a minimum of 12 weeks.

Forte80™ is suitable for long-term use. However, individuals who are immunocompromised or undergoing immunosuppressive therapy should consult a healthcare professional before starting the supplement.
Supporting Digestive Comfort and Metabolic Balance with Forte80™
With its innovative formulation and robust stability, Forte80™ provides targeted relief from common gastrointestinal side effects associated with GLP-1 therapy while promoting overall digestive and metabolic health. The supplement’s consistent potency and comprehensive support empower users to maintain medication adherence and optimise wellness.
Forte80™ is a reliable choice for anyone seeking scientifically supported GLP-1 probiotics.
Learn more about Forte80™
This article has been written with information taken from supported scientific research, and its purpose is purely educational. It should not be intended as medical advice or be used in personal diagnoses. Individuals on GLP-1 weight loss drugs should work closely with healthcare providers to develop a comprehensive, holistic health plan. With proper support, including targeted supplementation for digestive health, many more people may be able to benefit from these groundbreaking medications without sacrificing comfort or quality of life.
References:
- https://www.forte80.com/blogs/news/what-are-glp-1-drugs
- https://www.forte80.com/blogs/news/what-is-ozempic
- https://www.forte80.com/blogs/news/what-is-wegovy
- https://www.forte80.com/blogs/news/what-is-zepbound
- https://www.forte80.com/blogs/news/what-is-mounjaro
- https://www.forte80.com/blogs/news/what-is-rybelsus-a-guide-to-the-oral-glp-1-medication
- https://www.forte80.com/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9821052/
- https://www.nature.com/articles/nature12820
- https://onlinelibrary.wiley.com/doi/abs/10.1111/nbu.12396?msockid=157f2588a54e67ac07db31f3a46f6603
- https://microbialcellfactories.biomedcentral.com/articles/10.1186/1475-2859-13-S1-S7
- https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-021-01093-y
- https://pubmed.ncbi.nlm.nih.gov/25186587/
- https://pubmed.ncbi.nlm.nih.gov/27126957/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8622130/
- https://www.nmi.health/wp-content/uploads/2023/01/NMJ_LGG_A-Review-of-Clinical-Use-and-Efficacy.pdf
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3908359/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10150049/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10773886/
- https://pubmed.ncbi.nlm.nih.gov/19207856/
- https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/pmic.200300497